May 1, 2017
CPTR receives $1.1 million grant, partners with TGen to advance TB research
Related Posts
-
Workshop: RDCA-DAP 2020 Virtual Workshop -
Neonatal Adverse Events Severity Scale on NIH website -
Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes , September 2019
-
C-Path Partners with CHDR to Expand Global Collaborations -
C-Path’s PSTC, D-RSC Receive Positive FDA Response for Drug-Induced Skeletal Muscle Injury Biomarkers